CSIMarket
 
H cyte Inc  (HCYT)
Other Ticker:  
 
 
Price: $5.9900 $0.24 4.174%
Day's High: $5.99 Week Perf: -4.16 %
Day's Low: $ 5.99 30 Day Perf: 29701 %
Volume (M): 0 52 Wk High: $ 7.00
Volume (M$): $ 1 52 Wk Avg: $0.51
Open: $5.99 52 Wk Low: $0.01



 Market Capitalization (Millions $) 2
 Shares Outstanding (Millions) 0
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -10
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

H Cyte Inc


   Company Address: 2202 N. West Shore Blvd Tampa 33607 FL
   Company Phone Number: 633-6839   Stock Exchange / Ticker: HCYT
   HCYT is expected to report next financial results on February 24, 2023.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Finnovate Acquisition Corp

The evolving company from the Blank Checks sector the Finnovate Acquisition Corp issued the fiscal interval ending third quarter of 2022, numbers

Trailing the big players in the Blank Checks industry, a few overlooked corporations are coming in with the respective results. Finnovate Acquisition Corp mentioned it has reported operating shortfall of $-0.290025 millions, for the third quarter of 2022.

Eton Pharmaceuticals Inc

Eton Pharmaceuticals Inc has failed to turn into profitability in spite of epic Surge in Sales in the third quarter of 2022 earnings season

Eton Pharmaceuticals Inc announced very solid Sales advance of 315.355 % year on year to $3.22 millions in the financial span ending September 30 2022, but lost money at $-0.12.

Belpointe Prep Llc

In spite of the boost in Sales Profitability not Reached by in the third quarter of 2022

Belpointe Prep Llc announced in the most recent fiscal period surge in Sales by 21.583 % to $0.34 millions from the corresponding financial reporting period a year before, but it has Deficit has expanded at $-0.30 per share.

Bitech Technologies Corporation

For the third quarter of 2022 company reached zero gain of $0.00 per share compare to $0.00 a year prior and from $-0.01 per share from the preceding reporting season.

Sales remained unscathed to $0.00 millions from $0.09 millions in the same reporting season a year prior and sequentially Sales advanced from $0.08 millions.

Bioxytran Inc

Bioxytran Inc announced operating surplus of $0.014225 millions, in the third quarter of 2022 financial report

While the July to September 30 2022 reporting season resumes, countless entities have disclosed the respective numbers. In the thick of it, have been several constituents of the Major Pharmaceutical Preparations industry. And now, BIXT disclosed operating surplus of $0.014225 millions, for the July to September 30 2022 time-frame.






 
  Company Estimates
  Revenue Outlook
Bioxytran Inc does not provide revenue guidance.

Earnings Outlook
Bioxytran Inc does not provide earnings estimates.

Geographic Revenue Dispersion


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PONOU's Profile

Stock Price

PONOU's Financials

Business Description

Fundamentals

Charts & Quotes

PONOU's News

Suppliers

PONOU's Competitors

Customers & Markets

Economic Indicators

PONOU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071